Abstract
Purpose
The extraction of proteins from PLGA/PLA microspheres by a two-immiscible liquid phases system with the addition of surfactants was investigated.
Methods
First, the extraction without surfactants and the interaction between proteins (IFN-α2b and EGF) and empty microspheres (PLGA or PLA) was studied. Next, proteins stability in presence of different surfactants was evaluated by: (1) bicinchoninic acid protein assay, (2) reversed phase-high performance liquid chromatography, and (3) enzyme-linked immunosorbent assay. Then, proteins were extracted with PBS/dichloromethane including selected surfactants and characterized by the above mentioned techniques, biological activity tests, sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrospray ionization mass spectrometry.
Results
Without surfactants, protein recovery was only 27–43% for IFN-α2b and 58–73% for EGF. Protein content in solutions incubated with blank microspheres decreased to 66% for IFN-α2b and 86% for EGF. It was only possible to quantify the EGF and IFN-α2b in the same manner as in PBS alone when the surfactant added was Pluronic F-68 and SDS, respectively. Addition of these surfactants allowed the complete isolation of both biomolecules from the microspheres. The extraction procedure did not affect the encapsulated proteins.
Conclusion
Proteins can be quantitatively extracted, without changes, from PLGA/PLA microspheres using PBS/dichloromethane system that include an appropriate surfactant.
Similar content being viewed by others
Abbreviations
- BCA:
-
bicinchoninic acid
- EGF:
-
epidermal growth factor
- ELISA:
-
enzyme-linked immunosorbent assay
- ESI-MS:
-
electrospray ionization mass spectrometry
- IFN:
-
interferon
- mAb:
-
monoclonal antibody
- PLA:
-
poly (L-lactide)
- PLGA:
-
poly (DL-lactide-co-glycolide)
- PVA:
-
polyvinyl alcohol
- RP-HPLC:
-
reversed-phase high performance liquid chromatography
- SDS-PAGE:
-
sodium dodecylsulfate-polyacrylamide gel electrophoresis
References
Pisal DS, Kosloski MP, Balu-Iyer SV. Delivery of therapeutic proteins. J Pharm Sci. 2010;99(6):2557–75.
Ye M, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release. 2010;146(2):241–60.
Bilati U, Allémann E, Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm. 2005;59(3):375–88.
Fu K, Klibanov AM, Langer R. Protein stability in controlled-release systems. Nat Biotechnol. 2000;18(1):24–5.
Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90(3):261–80.
Johnson OL, Cleland JL, Lee HJ, Charnis M, Duenas E, Jaworowicz W, Shepard D, Shahzamani A, Jones AJ, Putney SD. A month-long effect from a single injection of microencapsulated human growth hormone. Nat Med. 1996;2(7):795–9.
Saez V, Ramon JA, Aldana R, Pérez D, Hardy E. Microencapsulation of recombinant interferon α-2b into poly (D, L-lactide-co-glycolide) microspheres. Biotecnol Apl. 2008;25(1):31–41.
Kim HK, Park TG. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Biotechnol Bioeng. 1999;65(6):661–7.
Kim HK, Park TG. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D, L-lactic-co-glycolic acid) microspheres: morphological effect on protein release. J Control Release. 2004;98(1):115–25.
Crotts G, Park TG. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J Microencapsul. 1998;15(6):699–713.
Ravivarapu HB, Burton K, DeLuca PP. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Eur J Pharm Biopharm. 2000;50(2):263–70.
Woo BH, Kostanski JW, Gebrekidan S, Dani BA, Thanoo BC, DeLuca PP. Preparation, characterization and in vivo evaluation of 120-day poly(D, L-lactide) leuprolide microspheres. J Control Release. 2001;75(3):307–15.
Deng XM, Li XH, Yuan ML, Xiong CD, Huang ZT, Jia WX, Zhan YH. Optimization of preparative conditions for poly-DL-lactide-polyethylene glycol microspheres with entrapped vibrio cholera antigens. J Control Release. 1999;58(2):123–31.
Sánchez A, Villamayor B, Guo Y, McIver J, Alonso MJ. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int J Pharm. 1999;185(2):255–66.
Gupta RK, Chang AC, Griffin P, Rivera R, Guo YY, Siber GR. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. Vaccine. 1997;15(6–7):672–8.
Sah H. Protein behavior at the water/methylene chloride interface. J Pharm Sci. 1999;88(12):1320–5.
Blanco D, Alonso MJ. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur J Pharm Biopharm. 1998;45(3):285–94.
Crotts G, Park TG. Stability and release of bovine serum albumin encapsulated within poly(D, L-lactide-co-glycolide) microparticles. J Control Release. 1997;44(2):123–34.
Calnan DP, Fagbemi A, Berlanga-Acosta J, Marchbank T, Sizer T, Lakhoo K, Edwards A, Playford R. Potency and stability of C truncated human epidermal growth factor. Gut. 2000;47(5):622–7.
Sinha A, Nightingale J, West KP, Berlanga-Acosta J, Playford RJ. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med. 2003;349(4):350–7.
Santana H, Espino Y, Franco A, Furrazola G, Hardy E. A sandwich-type enzyme-linked immunosorbent assay for the analysis of recombinant human interferon α-2b. Biotech Tech. 1999;13(5):341–6.
Ferrero J, Ochagavía ME, Aguilera A, López-Saura P. Interferon antiviral activity titration using the “SUMA” device system. Biotecnol Apl. 1994;11(1):34–42.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–5.
Martínez M, Currás T, Pérez E, Acosta A, Rojas I, Almazán M, Moya G, Pérez LC. Control analítico y especificaciones de calidad del factor de crecimiento epidérmico humano recombinante usado Como materia prima activa en formulaciones farmacéuticas. Biotecnol Apl. 1994;11(1):78–82.
Giteau A, Venier-Julienne MC, Aubert-Pouëssel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm. 2008;350(1–2):14–26.
Jiang G, Woo BH, Kang F, Singh J, DeLuca PP. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D, L-lactide-co-glycolide) microspheres. J Control Release. 2002;79(1–3):137–45.
Freyre FM, Vázquez J, Duarte C, Ferrá E, López I, Arteaga N. Anticuerpos monoclonales que reconocen los factores de crecimiento epidérmico humano y murino. Interferón y Biotecnología. 1989;6(1):32–46.
Puchades Y, Ojalvo AG, García Y, Chinea G, Gerónimo H, Vispo NS. Identification of peptide mimics of the epitope recognized by CB-EGF1, a monoclonal antibody EGF specific. Biotecnol Apl. 2005;22(3):203–6.
Emami J, Hamishehkar H, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A. A novel approach to prepare insulin-loaded poly (lactic-Co-glycolic acid) microcapsules and the protein stability study. J Pharm Sci. 2009;98(5):1712–31.
Woo BH, Jiang G, Jo YW, DeLuca PP. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res. 2001;18(11):1600–6.
Zhou S, Sun J, Sun L, Dai Y, Liu L, Li X, Wang J, Weng J, Jia W, Zhang Z. Preparation and characterization of interferon-loaded magnetic biodegradable microspheres. J Biomed Mater Res B Appl Biomater. 2008;87(1):189–96.
Al-Haushey L, Bolzinger MA, Fessi H, Briancon S. RhEGF microsphere formulation and in vitro skin evaluation. J Microencapsul. 2010;27(1):14–24.
Bodo G, Maurer-Fogy I. Characterization of different molecular species in affinity purified recombinant human interferon alpha 2. In: Dianzani F, Rossi GB, editors. The interferon system, vol. 24. New York: Raven; 1986. p. 23–7.
Lu HS, Chai JJ, Li M, Huang BR, He CH, Bi RC. Crystal structure of human epidermal growth factor and its dimerization. J Biol Chem. 2001;276(37):34913–7.
Acknowledgments and Disclosures
We would like to thank MSc. Haydee Gerónimo, Olga Brito and Joaquín González for EGF and IFN-α2b biological activity assays. We are also grateful to MSc. Yanet Terrero for the RP-HPLC analysis of EGF samples. The authors really appreciate the invaluable help of BSc. Yosep Rodríguez, MSc. Jesús Noda and Dr. Vladimir Besada for performing the ESI-MS analyses.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saez, V., Ramón, J.A., Caballero, L. et al. Extraction of PLGA-Microencapsulated Proteins Using a Two-Immiscible Liquid Phases System Containing Surfactants. Pharm Res 30, 606–615 (2013). https://doi.org/10.1007/s11095-012-0916-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-012-0916-0